
Tesamorelin is a synthetic GHRH analogue research peptide available in Dubai and the UAE, supplied as 32mg per pre-filled injection pen with published HPLC purity results.Tesamorelin consists of the full 44-amino-acid GHRH sequence with a trans-3-hexenoic acid group at the N-terminus, improving stability and half-life compared to native GHRH. It is the only FDA-approved GHRH analogue and among the most extensively characterised growth hormone-releasing peptides in clinical research.

